Prognosis of Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization(MC-hccAI 001): Development and Validation of the ALFP Score

Prognosis of Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization(MC-hccAI 001): Development and Validation of the ALFP Score

Baocuo Gong,1,2,* Xuewen Wang,1,3,* Wanting Guo,1 Hongyi Yang,1 Yanhong Shi,1 Yaying Chen,1 Simiao Gao,1 Jialin Chen,1 Lifang Liu,2 Linbin Lu,1 Xiong Chen1 On behalf of Fujian HCC-biomarker Study Group1Department of Oncology, Mengchao Hepatobiliary Hospital of Fujian Medical Universi...

Full description

Bibliographic Details
Main Authors: Gong B, Wang X, Guo W, Yang H, Shi Y, Chen Y, Gao S, Chen J, Liu L, Lu L, Chen X
Format: Article
Language:English
Published: Dove Medical Press 2023-08-01
Series:Journal of Hepatocellular Carcinoma
Subjects:
albumin-bilirubin grade；α-fetoprotein； prothrombin time； transarterial chemoembolization； hepatocellular carcinoma.
Online Access:https://www.dovepress.com/prognosis-of-patients-with-hepatocellular-carcinoma-treated-with-trans-peer-reviewed-fulltext-article-JHC

Internet

https://www.dovepress.com/prognosis-of-patients-with-hepatocellular-carcinoma-treated-with-trans-peer-reviewed-fulltext-article-JHC

Similar Items